Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar 30;29(4):e149-e152.
doi: 10.1093/eurjpc/zwab096.

Under-prescription of direct oral anticoagulants for treatment of non-valvular atrial fibrillation and venous thromboembolism in the COVID-19 lockdown period

Graziano Onder  1 , Pier Paolo Olimpieri  2 , Simone Celant  2 , Andrea Di Lenarda  3 , Giuseppe Ambrosio  4 , Gianpaolo Reboldi  5 , Gianfranco Gensini  6 , Antonietta Colatrella  2 , Katie Palmer  7 , Domenico Gabrielli  8 , Pierluigi Russo  2 ; AIFA Monitoring Registries Group
Collaborators, Affiliations

Under-prescription of direct oral anticoagulants for treatment of non-valvular atrial fibrillation and venous thromboembolism in the COVID-19 lockdown period

Graziano Onder et al. Eur J Prev Cardiol. .
No abstract available

Keywords: Atrial fibrillation; COVID-19; Direct oral anticoagulants; SARS-CoV-2; Venous thromboembolism.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Temporal trend in new prescriptions of non-vitamin K oral anticoagulants for treatment of non-valvular atrial fibrillation (upper panel) and venous thromboembolism (lower panel) from 2016 up to July 2020. Observed values are represented as a black coloured continuous line, while estimates are represented as a dashed light-blue line. Confidence intervals for March–July estimates are represented as a light-blue area.
See this image and copyright information in PMC

References

    1. Monsuez JJ. Cardiology practice in the COVID-19 era. Eur J Prev Cardiol 2020;27:1133–1135. - PMC - PubMed
    1. Olimpieri PP, Di Lenarda A, Mammarella F, Gozzo L, Cirilli A, Cuomo M, Gulizia MM, Colivicchi F, Murri G, Gabrielli D, Trotta F.. Non-vitamin K antagonist oral anticoagulation agents in patients with atrial fibrillation: Insights from Italian monitoring registries. Int J Cardiol Heart Vasc 2020;26:100465. - PMC - PubMed
    1. Wickham H. ggplot2: Elegant Graphics for Data Analysis. New York: Springer-Verlag, 2016. ISBN 978-3-319-24277-4.
    1. Hyndman R, Athanasopoulos G, Bergmeir C, Caceres G, Chhay L, O'Hara-Wild M, Petropoulos F, Razbash S, Wang E, Yasmeen F. forecast: Forecasting functions for time series and linear models. R package version 8.13, 2020.
    1. Holt A, Gislason GH, Schou M, Zareini B, Biering-Sørensen T, Phelps M, Kragholm K, Andersson C, Fosbøl EL, Hansen ML, Gerds TA, Køber L, Torp-Pedersen C, Lamberts M.. New-onset atrial fibrillation: incidence, characteristics, and related events following a national COVID-19 lockdown of 5.6 million people. Eur Heart J 2020;41:3072–3079. - PMC - PubMed

Publication types

MeSH terms